New Advances in Chemical Research in 2021. Reactions catalyzed within inorganic and organic materials interfaces commonly occur at high coverage, causing turnover rates to depend strongly on interfacial structure and composition, In a patent, 2682-49-7, name is Thiazolidin-2-one, introducing its new discovery. category: thiazolidine
Fungal infections have become ubiquitous diseases and their persistent nature and development of drug resistance have led to a global threat. Thereby urgent need to develop efficient antifungal agents is a must. Menace of protozoal diseases cannot be ruled out as the vaccines are not available currently and available anti-protozoal drugs are of low efficacy. Multidrug-resistant tuberculosis is responsible for the inefficient treatment of tuberculosis. Regarding cancer control, the five-membered heterocyclic compounds such as triazoles and tetrazoles are significant pharmacores that play prominent roles in drug design. In this regard, the research is being carried out in the field of drug design and synthesis considering azole-containing scaffolds as promising target molecules. In this review, the research on azoles having inhibitory properties against various disease causative factors such as fungi, protozoa, bacteria, mycobacteria, etc and various cancer cell lines is described. The whole research is classified on the basis of the type of the azole pharmacore on which the drug molecules are synthesized. The pharmacology of the designed molecules is expressed alongside emphasizing the moieties responsible for the potent activity. Besides, possible structural modification speculating higher biological properties is demonstrated based on SAR.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.category: thiazolidine. In my other articles, you can also check out more blogs about 2682-49-7
Reference:
Quinuclidine – Wikipedia,
Quinuclidine | C7H268N | ChemSpider